179 related articles for article (PubMed ID: 7700899)
21. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
22. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
Uckun FM; Myers DE
J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
[TBL] [Abstract][Full Text] [Related]
23. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation in adult acute lymphoblastic leukaemia.
Wojnar J; Hołowiecki J; Krawczyk-Kuliś M; Markiewicz M; Wojciechowska M; Kyrcz-Krzemień S; Kopera M; Kruzel T; Kachel L
Transplant Proc; 1996 Dec; 28(6):3518-21. PubMed ID: 8962368
[No Abstract] [Full Text] [Related]
25. Prognostic factors for autologous bone marrow transplantation in acute leukaemia: a single centre study of 105 patients.
Cordonnier JM; Mercier M; Plouvier E; Hervé P; Cahn JY
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):293-300. PubMed ID: 7971248
[TBL] [Abstract][Full Text] [Related]
26. New approaches for bone marrow purging.
Beaujean F; Hervé P
Transfus Sci; 1992; 13(4):431-42. PubMed ID: 10150140
[No Abstract] [Full Text] [Related]
27. [Estimation of megakaryothrombopoiesis by mean platelet volume in leukemia patients during the course of chemotherapy and patients undergoing bone marrow transplantation].
Gondo K; Miyachi H; Tanaka Y; Kawada T; Kato S; Arimori S; Ando Y
Rinsho Ketsueki; 1993 Jul; 34(7):835-41. PubMed ID: 8360987
[TBL] [Abstract][Full Text] [Related]
28. Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.
Gribben JG; Nadler LM
Important Adv Oncol; 1993; ():139-56. PubMed ID: 8505048
[No Abstract] [Full Text] [Related]
29. [Acute leukemia: autologous transplantation of bone marrow cells grown in long-term culture containing low molecular weight natural tumour suppressor].
Yang K; Teng AP; Pei ZT
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):287-9, 325-6. PubMed ID: 7953919
[TBL] [Abstract][Full Text] [Related]
30. Purging multidrug resistant cells from bone marrow.
Chao NJ; Aihara M; Kühl JS; Sikic BI; Blume KG
Prog Clin Biol Res; 1992; 377():13-23. PubMed ID: 1438409
[No Abstract] [Full Text] [Related]
31. Marrow purging for autologous bone marrow transplantation.
Combaret V; Favrot MC; Philip T
Targeted Diagn Ther; 1989; 2():137-54. PubMed ID: 2519544
[No Abstract] [Full Text] [Related]
32. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
Schrøder H; Clausen N; Thorling K; Hokland P
Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
[TBL] [Abstract][Full Text] [Related]
33. [Successful high-dose chemotherapy combined with autologous bone marrow transplantation in a case of refractory follicular lymphoma].
Nagai T; Hirayama Y; Ohta H; Koyama R; Matsunaga T; Kuga T; Sakamaki S; Niitsu Y
Rinsho Ketsueki; 1997 Jun; 38(6):513-9. PubMed ID: 9248327
[TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow purging with LAK cells.
Giuliodori L; Moretti L; Stramigioli S; Luchetti F; Annibali GM; Baldi A
Int J Artif Organs; 1993 Dec; 16 Suppl 5():108-10. PubMed ID: 8013966
[TBL] [Abstract][Full Text] [Related]
35. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
36. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Bishop MR; Warkentin PI; Jackson JD; Bayever E; Iversen PL; Whalen VI; Lastovica J; Haines K; Kessinger A
Prog Clin Biol Res; 1994; 389():183-7. PubMed ID: 7700901
[No Abstract] [Full Text] [Related]
38. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
39. Use of etoposide in combination with cyclosporine for purging multidrug resistant leukemic cells from bone marrow in a mouse model.
Kühl JS; Sikic BI; Blume KG; Chao NJ
Prog Clin Biol Res; 1992; 377():25-34. PubMed ID: 1438422
[No Abstract] [Full Text] [Related]
40. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
Mizuta S; Kawano A
Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
